INTRODUCTION AND OBJECTIVES: Acute ureteral stent encrustation (USE) is a commonly encountered problem that can increase stent morbidity and make stone treatment challenging. Previous research into USE has focused on the physical and biochemical properties of ureteral stents to decrease encrustation. To date, this research has proven generally unsuccessful. To our knowledge, no detailed data exists on individual patient characteristics of early stent encrusters. We sought to characterize this population in order to identify risk factors associated with acute USE.
METHODS: An IRB approved prospective study was designed to identify patients with early USE, defined as a calcified stent identified within 3 months of stent placement. From June 2016 to October 2016 all patients with indwelling ureteral stents were screened. Patients with stent encrustation were identified. Demographic data, past medical history, indwelling time of stent, stent size, and stent manufacturer were collected. Additionally, at the time stent removal, urine analysis, urine culture, stent culture, stone culture, encrusted stent stone analysis, and ureteral stone analysis were obtained.
RESULTS: Seventy-six consecutive patients undergoing ureteroscopy and stent placement were screened. 9.2% of cases demonstrated early USE. Average age of our cohort was 46 years old (STD 5.1) and 57% of patients were female. Urinary tract stones were found in the ureter (60%) and renal pelvis (40%). Average BMI was 26.2 (STD 6.3). No patient had identifiable metabolic stone disease. All patients had normal baseline renal function (GFR>60). The median indwelling stent time was 56 days (IQR 44-69 days). 57% of patients had a positive urine culture taken at time of stent removal. In 71% of patients, the major stone composition for USE and urinary tract stones was brushite (range 60-100%). Stone and calcified stent cultures were positive in 4 of 7 patients, but were never the same organism isolated in urine culture. Only 1 patient had an encrusted stent consistent with struvite. Furthermore, Streptococcus species were isolated in 50% of encrusted stent cultures. One patient had a positive stent culture with a negative concomitant urine culture.
CONCLUSIONS: In our series, the most common calcification associated with acute USE was brushite stones. Additionally, stone and calcified stent cultures were positive with organisms dissimilar from those isolated in the urine. Stone and calcified stent cultures should be obtained in this group of patients, principally if stent exchange or additional procedures are required.
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MP01-02
A NOMOGRAM FOR PREDICTING URETERAL STONE PASSAGE Vishnu Ganesan*, Michael Kattan, Cleveland, OH; Christopher Loftus, Seattle, WA; Bryan Hinck, Daniel Greene, Yaw Nyame, Sri Sivalingam, Manoj Monga, Cleveland, OH INTRODUCTION AND OBJECTIVES: Medical expulsive therapy (MET) is frequently used for patients with ureteral stones who present to the emergency department (ED). Our goal was to develop and validate a nomogram to predict the probability stone passage on MET for ureteral stones.
METHODS: We reviewed ED visits within our health system with an ICD-9 diagnosis of urolithiasis, an associated CT scan, and discharged on MET between 2010-2013. CT's were reviewed to confirm stone size, location, and associated hydronephrosis. The primary outcome was spontaneous stone passage within 90-days of initial ED visit. Patients with no documented follow up in our system were called to collect data on stone passage. A nomogram was developed using variables chosen for clinical and statistical significance and validated internally using a bootstrapping technique.
RESULTS: 1,424 ED visits met the inclusion criteria and of these, 1,146 (80.4%) had confirmed ureteral stones on CT. Patients lost to follow up and who were unreachable by phone were excluded, leaving 661 patients to build the final model. The median age was 50 years (IQR 38-59) with 419 (63.4%) males and a median stone size of 4.0 mm (IQR 3.0-5.2). A majority of patients, 422 (64%), spontaneously passed their stone while the remaining underwent a procedure. On univariable analysis, patients who passed stones tended to have smaller stones (3.6 mm vs 5.2 mm, p < 0.001), stones in the distal ureter (73% vs. 41%, p < 0.001), and significantly higher WBC counts (9.49 vs. 8.57, p < 0.001). There were no associations between age (49 vs. 50, p ¼ 0.831) or gender (64% male vs. 62% male, p ¼ 0.451) on stone passage. In the multivariable model, stone size (per 1 mm increase; OR 0.49, 95% CI 0.43-0.57, p < 0.001), stone location (p < 0.0001), a prior history of stone passage (OR 1.74, 95% CI 1.04 -2.93, p ¼ 0.036), and WBC count (per 1k/uL increase, OR 1.12, 95% CI 1.04-1.21, p ¼ 0.001) were significantly associated with spontaneous stone passage. The model was validated internally (bootstrap-adjusted concordance index, 0.80) and demonstrated excellent calibration.
CONCLUSIONS: For patients presenting with ureteral stones in the ED amenable to observation, we have developed a model to predict the probability of stone passage. Early follow-up or intervention for patients with a low probability of stone passage could improve patient satisfaction and prevent costly ED returns.
Source of Funding: None
MP01-03 PATIENT CENTERED FACTORS INFLUENCING URETERAL STONE PASSAGE
Andrew Portis*, Jennifer Portis, Suzanne Neises, St Paul, MN INTRODUCTION AND OBJECTIVES: Patients generally prefer to avoid surgery for ureteral stones. The initial management decision is a leap of faith influenced by patient and physician experiences and preferences. We explore the impact of patient centered factors on initial decision making.
METHODS: As an element of an ongoing quality improvement program, patients presenting to a subspecialty stone clinic after discharge from Emergency Department were identified. Inclusion criteria were unilateral ureteral stone <¼ 10mm on computed tomography and freedom from infection. Patients completed PROMIS pain intensity and pain interference symptom surveys (PROMIS score of 60 Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 THE JOURNAL OF UROLOGY â e1
